Acadian Asset Management
BDTX icon

Acadian Asset Management’s Black Diamond Therapeutics BDTX Stock Holding History

Acadian Asset Management’s Portfolio BDTX Stock Details BDTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.34M Hold
2,348,651
– – 0.01% 847
2026
Q1 		$5M Buy
2,348,651
+718,478
+44% +$1.71M 0.01% 715
2025
Q4 		$3.96M Buy
1,630,173
+1,149,050
+239% +$4.07M 0.01% 715
2025
Q3 		$1.82M Buy
+481,123
New +$1.41M ﹤0.01% 915
2025
Q2 		– Sell
-14,971
Closed -$23K – 1661
2025
Q1 		$23K Sell
14,971
-5,194
-26% -$10.9K ﹤0.01% 1520
2024
Q4 		$42K Buy
+20,165
New +$57.8K ﹤0.01% 1479
2024
Q2 		– Sell
-170,510
Closed -$864K – 1749
2024
Q1 		$864K Buy
170,510
+20,616
+14% +$83.1K ﹤0.01% 883
2023
Q4 		$420K Buy
+149,894
New +$352K ﹤0.01% 1064
2023
Q3 		– Sell
-53,365
Closed -$268K – 1651
2023
Q2 		$268K Hold
53,365
– – ﹤0.01% 1205
2023
Q1 		$99K Hold
53,365
– – ﹤0.01% 1396
2022
Q4 		$95K Buy
+53,365
New +$96.1K ﹤0.01% 1447

Other funds holding BDTX

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $52.8B AUM 58.98% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Acadian Asset Management's BDTX Position: Q2 2026 in Review

Acadian Asset Management held its Black Diamond Therapeutics (BDTX) position steady in Q2 2026 at 2,348,651 shares worth $4.34M. The position accounts for 0.01% of the portfolio, ranked #847.

Acadian Asset Management first reported a position in BDTX in Q4 2022 and has held it in 11 quarters since. The position peaked at $5M in Q1 2026. 79 funds tracked by Wall St. Rank hold BDTX as of Q2 2026.

  • Acadian Asset Management held 2,348,651 shares of Black Diamond Therapeutics worth $4.34M as of Q2 2026.
  • Acadian Asset Management left its Black Diamond Therapeutics share count unchanged in Q2 2026.
  • Black Diamond Therapeutics made up 0.01% of Acadian Asset Management's portfolio in Q2 2026, its #847 holding.
  • Acadian Asset Management first reported a position in Black Diamond Therapeutics in Q4 2022 and has held it in 11 quarters since.
  • Acadian Asset Management's Black Diamond Therapeutics position peaked at $5M in Q1 2026.
  • 79 funds tracked by Wall St. Rank held Black Diamond Therapeutics as of Q2 2026.

Based on Acadian Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.